3 exciting ASX healthcare shares to buy in May

CSL Limited (ASX:CSL) and these ASX healthcare shares could be worth considering in May. Here's why I like them…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Due to a number of positive tailwinds including increased chronic disease burden and ageing populations, I believe the healthcare sector is one of the best places to invest your money with a long term view.

And the good news is that there's no shortage of options in the space for investors to choose from.

With that in mind, here are three options in the sector to consider:

Alcidion Group Ltd (ASX: ALC)

If you're interested in small cap shares then you might want to take a look at Alcidion. It is a fast-growing health informatics company which is aiming to transform healthcare with smart, intuitive technology solutions. It has a growing portfolio of software products and services that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes.

CSL Limited (ASX: CSL)

And at the big end of the market you'll find this global biotherapeutics company. I believe CSL is the highest quality company Australia has to offer and capable of generating strong returns for investors over the long term. Especially given its leading therapies, lucrative plasma collection network, and its research and development pipeline. The latter is underpinned by high level of investment each year by the company. For example, in FY 2019 CSL invested a massive US$832 million in R&D activities across its businesses.

ResMed Inc. (ASX: RMD)

Finally, I think ResMed is another healthcare share to consider with a long term view. This medical device company has been growing at a very strong rate over the last few years thanks to its sleep treatment business. The proliferation of sleep apnoea has been driving very strong demand for both its hardware and its software. Given how many people globally are believed to be undiagnosed sufferers of sleep apnoea, I believe ResMed has a significant runway for growth. Though, with its third quarter update due to be released tomorrow, it might be prudent to wait for that before investing.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd and CSL Ltd. The Motley Fool Australia has recommended Alcidion Group Ltd and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Sports fans looking at smart phone representing surging pointsbet share price
Growth Shares

Up 111% in six months, this soaring ASX share is backed to keep rising

One fund manager thinks this ASX growth share can continue its phoenix performance.

Read more »

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

These ASX growth shares are being tipped to smash the market

Returns of 14% to 68% could be on the cards for buyers of these shares according to brokers.

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Growth Shares

These ASX 200 growth shares could rise 50% to 70%

Analysts are predicting these stocks to rise materially from current levels.

Read more »

A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
Growth Shares

2 ASX 300 growth shares with 'strong momentum' this fund manager says are buys

These two stocks have plenty of growth potential, according to experts.

Read more »

Rocket going up above mountains, symbolising a record high.
Growth Shares

2 high-growth ASX shares to buy now

Analysts at Bell Potter think these shares would be great picks for growth investors.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These ASX 200 growth stocks could rise 30% to 100%

Analysts think these shares are dirt cheap at current levels and have put buy ratings on them.

Read more »

Young woman using computer laptop smiling in love showing heart symbol and shape with hands. as she switches from a big telco to Aussie Broadband which is capturing more market share
Growth Shares

Goldman Sachs loves these ASX 200 growth shares: Do you own them?

Why is the broker bullish on them? Let's find out.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 super ASX growth shares to buy for huge returns

Analysts are feeling bullish about these shares. Let's see what they are saying about them.

Read more »